Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nav1.5 is a voltage-gated sodium channel primarily expressed in cardiac muscle, where it plays a critical role in the initiation and propagation of action potentials that trigger heartbeats. The channel is encoded by the SCN5A gene. Mutations or dysfunctions are linked to various inherited arrhythmia syndromes, making it a major target for antiarrhythmic therapies and genetic screening.
Blocks sodium ion flow through the channel pore
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-Gated Sodium Channel Nav1.5 (Nav1.5).